Trial Profile
The Study to Estimate the Long-Acting Effect of Insulin Degludec in Type 1 Diabetes: Using a Continuous Glucose Monitoring and Insulin Pump
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 28 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.